Wastage of Oral Cancer Drugs Costs More Than $4000 per Patient, Study Suggests
Researchers studied 22 oral cancer drugs and found that wastage due to dose modifications or discontinuations resulted in a mean cost of $4290 per patient.
Researchers studied 22 oral cancer drugs and found that wastage due to dose modifications or discontinuations resulted in a mean cost of $4290 per patient.
Young patients with lymphoma or rhabdomyosarcoma may experience changes in body composition during chemotherapy, research suggests.
After 3 or 4 doses, mRNA-based COVID-19 vaccines are similarly effective in patients with cancer and the general population, a study suggests.
The prevalence of certain cancers may be higher in lesbian, gay, and bisexual patients than in heterosexual patients, a large study suggests.
Treating advanced melanoma with immune checkpoint inhibitors can be safe and effective in patients with concomitant CLL, a study suggests.
Malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.
The overall incidence of pediatric cancer in the United States increased from 2003 to 2019, researchers found.
Experts describe how ChatGPT and other AI technologies will transform health care and research.
Medicaid expansion is associated with increased use of palliative care for patients with advanced cancer, a study suggests.
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients.